Advances in hepatitis C: What is coming in the next 5 years?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 4, 2002, Pages 442-447

  Locarnini, Stephen A ^a   Bartholomeusz, Angeline ^a  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Antiviral agents; cis acting elements; Helicase; Hepatitis C virus; Non structural proteins; Polymerase; Protease

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; METALLOPROTEINASE; RIBAVIRIN; SERINE PROTEINASE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS PROTEIN; VIRUS RNA;

CHRONIC HEPATITIS; CONFERENCE PAPER; CRYSTALLIZATION; DISEASE COURSE; DRUG DESIGN; ENZYME ACTIVITY; GENOME; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REPLICON; VIRUS REPLICATION;

EID: 0036091674     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02768.x     Document Type: Conference Paper

References (45)

1. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial
2. Binding of hepatitis C virus to CD81
3. Low density lipo-protein receptor as a candidate receptor for hepatitis C virus
4. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
5. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
6. Gene mapping of the putative structural region of the hepatitis C virus genome byin vitro processing analysis
7. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: A potential mechanism of interferon resistance
8. Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus
9. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA
10. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA
11. Genetic organization and diversity of the 3′ noncoding region of the hepatitis C virus genome
12. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA
13. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee
14. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus
15. Replication of subgenomic hepatitis C virus RNA in a hepatoma cell line
16. A mouse model for hepatitis C virus infection?
17. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide
18. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site
19. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 A resolution structure in a hexagonal crystal form
20. Structure of the hepatitis C virus RNA helicase domain
21. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: The crystal structure provides insights into the mode of unwinding
22. Crystallization and preliminary X-ray crystallographic analysis of the helicase domain of hepatitis C virus NS3 protein
23. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site
24. Mutational analysis of the structure and functions of hepatitis C virus RNA-dependent RNA polymerase
25. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy
26. Expression and identification of hepatitis C virus polyprotein cleavage products
27. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus
28. In vitro characterization of a purified NS2/3 protease variant of hepatitis C virus
29. The conformation of hepatitis C virus NS3 proteinase with and without NS4A: A structural basis for the activation of the enzyme by its cofactor
30. Crystal structure of hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide
31. The hepatitis C virus NS3 proteinase: Structure and function of a zinc-containing serine proteinase
32. The RNA aptamer-binding site of hepatitis C virus NS3 protease
33. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3)
34. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA
35. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity
36. Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase
37. Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase
38. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system
39. Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinant
40. Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines
41. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes
42. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes
43. Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice
44. Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA
45. Inhibition of hepatitis C virus-directed gene expression by a DNA ribonuclease